Inactivation of the p53 protein in cell lines derived from human esophageal cancers

International Journal of Cancer

Volumn 71, Issue 1, 1997, Pages 79-87

  Barnas, Christoph ^a   Martel Planche, Ghyslaine ^a   Furukawa, Yoichi ^a   Hollstein, Monica ^b   Montesano, Ruggero ^a   Hainaut, Pierre ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA BINDING; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BASE SEQUENCE; BLOTTING, WESTERN; DNA; DNA DAMAGE; ESOPHAGEAL NEOPLASMS; HUMANS; HYDROGEN PEROXIDE; METHYL METHANESULFONATE; MUTAGENS; OXIDANTS; POINT MUTATION; PROMOTER REGIONS (GENETICS); RETROSPECTIVE STUDIES; RNA, MESSENGER; SEQUENCE DELETION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030928507     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970328)71:1<79::AID-IJC14>3.0.CO;2-4     Document Type: Article

References (33)

1. CHO, Y., GORINA, S., JEFFREY, P.D. and PAVLETICH, N.P., Crystal structure of a p53 tumor-suppress or DNA complex: understanding tumorigenic mutations. Science. 265, 346-355 (1994).
2. DAVIS, R.J., D'CRUZ, C.M., LOVELL, M.A., BIEGEL, J.A. and BARR, F.G., Fusion of PAX7 to FKHR by the variant t(1;13)(p36;ql4) translocation in alveolar rhabdomyosarcoma. Cancer Res., 54, 2869-2872 (1994).
3. DELMOLINO, L., BAND, H. and BAND, V., Expression and stability of p53 protein in normal human mammary epithelial cells. Carcinocenesis. 14, 827-832 (1993).
4. DRESSLER, G.R. and DOUGLASS, E.G., Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc. nat. Acad. Sci. (Wash.), 99, 1179-1183 (1992).
5. FUNK, W.D., PAK, D.T., KARAS, R.H., WRIGHT, W.E. and SHAY, J.W., A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. cell. Biol., 12, 2866-2871 (1992).
6. GALILI, N., DAVIS, R.J., FREDERICKS, W.J., MUKHOPADHYAY, S., RAUSCHER, F.J.3D., EMANUEL, B.S., ROVERA, G. and BARR, F.G., Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nature Genet., 5, 230-235 (1993).
7. HAINAUT, P., The tumor-suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr. Opin. Oncol., 7, 76-82 (1995).
8. HARRIS, N., BRILL, E., SHOHAT, O., PROKOCIMER, M., WOLF, D., ARAI, N. and ROTTER, V., Molecular basis for heterogeneity of the human p53 protein. Mol. cell. Biol. 6, 4650-4656 (1986).
9. HOLLSTEIN, M., SHOMER, B., GREENBLATT, M., SOUSSI, T., HOVIG, E., MONTESANO, R. and HARRIS, C.C., Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res., 24, 141-146 (1996).
10. HOLLSTEIN, M.C., METCALF, R.A., WELSH, J.A., MONTESANO, R. and HARRIS, C.C., Frequent mutation of the p53 gene in human esophageal cancer. Proc. nat. Acad. Sci. (Wash.). 87, 9958-9961 (1990).
11. HUANG, Y., MELTZER, S.J., YIN, J., TONG, Y., CHANG, E.H., SRIVASTAVA, S., MCDANIEL, T., BOYNTON, R.F. and ZOU, Z.Q., Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Cancer Res., 53, 1889-1894 (1993).
12. HUANG, Y., YIN, J. and MELTZER, S.J., A unique p53 intragenic deletion flanked by short direct repeats results in loss of mRNA expression in a human esophageal carcinoma. Carcinogenesis, 15, 1653-1655 (1994).
13. KAWASAKI, T., TOMITA, Y. WATANABE, R., TANIKAWA, T., KUMANISHI, T. and SATO, S., mRNA and protein expression of p53 mutations in human bladder-cancer cell lines. Cancer Lett., 82, 113-121 (1994).
14. KITAHARA, K., YASUI, W., YOKOZAKI, H., SEMBA, S., HAMAMOTO, T., HISATSUGU, T. and TAMARA, E., Expression of cyclin Dl. CDK4 and p27Kip1 is associated with the p16MTS1 gene status in human esophagealcarcinoma cell lines. J. exp. Ther. Oncol., 1, 7-12 (1996).
15. KO, L.J. and PRIVES, C., p53: puzzle and paradigm. Genes Dev., 10, 1054-1072 (1996).
16. LEHMAN, T.A., BENNETT, W.P., METCALF, R.A., WELSH, J.A., ECKER, J., MODALI, R.V., ULLRICH, S., ROMAND, J.W., APPELLA, E., TESTA, J.R., GERWIN, B.I. and HARRIS, C.C., p53 mutations, ras mutations, and p53-heat-shock-70-protein complexes in human lung-carcinoma cell lines. Cancer Res., 51, 4090-4096 (1991).
17. LIANG, Y.Y., ESTEVE, A., MARTEL-PLANCHE, G., TAKAHASHI, S., Lu, S.H., MONTESANO, R. and HOLLSTETN, M., p53 mutations in esophageal tumors from high-incidence areas of China. Int. J. Cancer, 61, 611-614 (1995).
18. MONTESANO, R., HOLLSTEIN, M. and HAINAUT, P., Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int. J. Cancer, 69, 1-11 (1996).
19. MUNOZ, N. and CASTELLSAGUÈ, X., Epidemiology of oesophageal cancer. Europ. J. Gastroentervl. Hepatol., 6, 649-655 (1994).
20. MURAKAMI, Y., HAYASHI, K. and SEKIYA, T., Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by singlestrand conformation polymorphism analysis. Cancer Res., 51, 3356-3361 (1991).
21. NISHIHIRA, T., HASHIMOTO, Y. KATAYAMA, M., MORI, S. and KUROKI, T., Molecular and cellular features of esophaaeal cancer cells. J. Cancer Res. clin. Oncol. 119, 441-449 (1993).
22. PARKIN, D.M., PISANI, P. and FERLAY, J., Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54, 594-606 (1993).
23. POLEEV, A., FICKENSCHER, H., MUNDLOS, S., WlNTERPACHT, A., ZABEL, B., FIDLER, A., GRUSS, P. and PLACHOV, D., PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors. Development, 116, 611-623 (1992).
24. PUISIEUX, A., GALVIN, K., TROALEN, F., BRESSAC, B., MARCAIS, C., GALUN, E., PONCHEL, E. YAKICIER, C., JI, J. and OZTURK, M., Retinoblastoma and p53 tumor-suppressor genes in human hepatoma cell lines. FASEB J., 7, 1407-1413 (1993).
25. ROLLEY, N., BUTCHER, S. and MILNER, J., Specific DNA binding by different classes of human p53 mutants. Oncogene, 11, 763-770 (1995).
26. STUART, E.T., HAFFNER, R., OREN, M. and GRUSS, P., Loss of p53 function through PAX-mediated transcriptional repression. EMBO J., 14, 5638- 5645 (1995a).
27. STUART, E.T., KIOUSSI, C., AGUZZI, A. and GRUSS, P., PAX5 expression correlates with increasing malignancy in human astrocytomas. Clin. Cancer Res., 1, 207-214 (1995b).
28. TAKAHASHI, T., NAU, M.M., CHIBA, I., BIRRER, M.J., ROSENBERG, R.K., VINOCOUR, M., LEVITT, M., PASS, H., GAZDAR, A.F, and MINNA, J.D., p53: a frequent target for genetic abnormalities in lung cancer. Science, 246, 491-194 (1989).
29. TANAKA, H., SHIBAGAKI, I., SHIMADA, Y., WAGATA, T., IMAMURA, M. and ISHIZAKI, K., Characterization of p53 gene mutations in esophageal squamous-cell-careinomacell lines: increased frequency and different spectrum of mutations from primary tumors. Int. J. Cancer, 65, 372-376 (1996).
30. TUCK, S.P. and CRAWFORD, L., Characterization of the human p53 gene promoter. Mol. cell. Biology, 9, 2163-2172 (1989).
31. YAGINUMA, Y. and WESTPHAL, H., Abnormal structure and expression of the p53 gene in human ovarian-carcinoma cell lines. Cancer Res., 52, 4196-4199 (1992).
32. YAMADA, Y., YOSHIDA, T., HAYASHI, K., SEKIYA, T., YOKOTA, J., HIROHASHKI, S., NAKATANI, K., NAKANO, H., SUGIMURA, T. and TERADA, M., p53 gene mutations in gastric-cancer metastases and in gastric-cancer cell lines derived from metastases. Cancer Res., 51, 5800-5805 (1991).
33. ZHOU, X., SUZUKI, H., SHIMADA, Y. IMAMURA, M., YIN, J., JIANG, H.Y. TARMIN, L., ABRAHAM, J.M. and MKLTZER, S.J., Genomic DNA and messenger RNA expression alterations of the CDKN2B and COKN2 genes in esophaaeal-squamous-carcinoma cell lines. Genes Chromosomes Cancer, 13, 285-290 (1995).